NCT00448214View on ClinicalTrials.gov

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

PHASE2CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Atrial Fibrillation
Interventions
DRUG

YM150

Oral

DRUG

warfarin

Oral

Trial Locations (18)

Unknown

Launceston

Pok Fu Lam

Shatin

Hokkaido

Kansai

Kanto

Kyusyu

Shikoku

Tōhoku

Kuala Lumpur

Hastings

Singapore

Bloemfontein

Seoul

Taipei

Bangkok

Chiang Mai

Nakhon Ratchasima

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY